Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 19/20 | 0.76 |
| ▸ | PGR | P06401 | 6/20 | 0.70 |
| ▸ | NR3C2 | P08235 | 10/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3650883 | 0.96 | NR3C1 (0.82) | NR3C1PGRNR3C2 | |
| SCHEMBL3651686 | 0.87 | NR3C1 (0.84) | NR3C1PGRNR3C2 | |
| SCHEMBL3642450 | 0.87 | NR3C1 (0.84) | NR3C1PGRNR3C2 | |
| SCHEMBL3651593 | 0.87 | NR3C1 (1.00) | NR3C1PGRNR3C2 | |
| SCHEMBL3652420 | 0.86 | NR3C1 (0.82) | NR3C1PGRNR3C2 | |
| SCHEMBL4827164 | 0.86 | NR3C1 (0.82) | NR3C1PGRNR3C2 | |
| SCHEMBL4823363 | 0.86 | NR3C1 (0.82) | NR3C1PGRNR3C2 | |
| SCHEMBL4827055 | 0.86 | NR3C1 (0.82) | NR3C1PGRNR3C2 | |
| SCHEMBL3652499 | 0.85 | NR3C1 (0.81) | NR3C1PGRNR3C2 | |
| SCHEMBL4825644 | 0.84 | NR3C1 (0.80) | NR3C1PGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1492771-A1 | QUINOLINE AND ISOQUINOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003082827-A1 | QUINOLINE AND ISOQUINOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-10-09 | — | — | WO | disclosed |